Photo: Zagorsk Optical and Mechanical Plant
Shvabe holding engineers have developed an ophthalmic analyzer for early-stage glaucoma detection. The device has been designed on the basis of a technique developed by Krasnov Research Institute of Eye Diseases.
The full name of the device is the ophthalmic analyzer of patient-specific normal intraocular pressure. The product developed by Zagorsk Optical and Mechanical Plant has successfully passed the engineering test and toxicity study at Russian Research and Test Institute for Medical Equipment and clinical study at Krasnov Research Institute of Eye Diseases and has been authorized as a medical device with the Federal Service for Supervision in Healthcare.
“At the incipient glaucoma stage, the disease is generally asymptomatic and this makes the diagnostics much more complicated. The device developed by Shvabe holding is designed to solve this problem. During the test, the analyzer has shown high measurement accuracy and processing efficiency for functional parameters of a patient’s eye,” said Oleg Evtushenko, Rostec’s Executive Director.
The technique offered by ophthalmology experts and implemented by Shvabe holding professionals is based on tolerable intraocular overpressure grading and the relevant glaucoma detection probability. Shvabe analyzer facilitates quick, safe and painless measurements.
All acquired data is processed by the measurement and calculation system built in the device, while the measurements can be sent to the ophthalmologist’s PC for downloading into a patient’s electronic health record.
